THE CORONAVIRUS & AURA AIR
EFFICACY RESULTS PUBLISHED
We believe that Aura Air is the first Filtration/Purification/Monitoring system in the world currently undergoing extensive efficacy tests, specifically related to its ability to reduce the levels of the COVID-19 Coronavirus aerosol droplets in the air, using a combination of a patented Copper impregnated HEPA Filter, the patented Sterionizer and UV-C light. These Clinical Trials are taking placing in a special laboratory at Sheba Medical Centre* that diagnoses and measures the levels of the COVID-19 Coronavirus in Laboratory conditions, using the latest, state of the art RNA measurement equipment – each unit costing nearly £100,000.
* Sheba Medical Center was ranked earlier this year by Newsweek as one of the Top 10 Hospitals in the World.
COPPER + HEPA = 99.97% REDUCTION
AURA AIR’S UNIQUE FILTRATION & DISINFECTION SYSTEM DEPLOYED AT SHEBA MEDICAL CENTRE TO HELP TO REDUCE COVID-19 INFECTION
“We started this pilot in order to help the ward in reducing potential infections. Now, we are focused on purifying and sterilising the air of resistant viruses, including coronavirus (Covid-19),” Aviad Schneiderman, Aura Air’s CEO, and founding partner said in a statement. “In light of our impressive results on the anti-bacterial front, Aura Air is in the final stages of approval for funding by the European Union, who set a goal to find solutions for closed-space infections, with a special emphasis on the Coronavirus.”
“In light of the impressive performance and results that Aura Air has achieved on the antibacterial level, we are in the final stages of receiving EU funding,” said Roy Friedberg, Vice President of Aura Air. “The goal is to target solutions for closed space infections in general, and the coronavirus in particular.”
Aura Air has completed three other pilots that have shown significant improvements in air quality — at a Hilton hotel, a conference room in a commercial building and a luxury residential apartment.